Заболела? Полечися!

2010-03-09

Immune system boost from Vitamin D? - NHS Choices

Filed under: Bayer Schering — admin @ 06:1

Some of the chemicals used in the study were provided by the manufacturer AG. The paper was published in the peer-reviewed scientific

(more…)

2010-03-08

Mehr Leistung durch Anbindung an ein fahrerloses Transportsystem - MM Maschinenmarkt

Filed under: Bayer Schering — admin @ 16:1

Bei der AG am Standort Leverkusen wurde der Parenteralia-Betrieb an das vorhandene fahrerlose Transportsystem (FTS) angeschlossen

(more…)

2010-03-07

La píldora cumple medio siglo - Diario EL PAIS

Filed under: Bayer Schering — admin @ 18:1

Medio siglo pasó desde que esa primera píldora, Enovid, de la compañía Searle, se introdujera en el mercado norteamericano, y que seis meses después

(more…)

Preisgekrönter Biotech-Dienstleister - FAZ - Frankfurter Allgemeine Zeitung

Filed under: Bayer Schering — admin @ 16:1

Zweitens will das Unternehmen des Umweltpreisträgers der dabei helfen, künftig mehr Wirkstoff in kürzerer Zeit herzustellen

(more…)

2010-03-06

USAID cooperates with pharmacies to promote pregnancy planning - Trend News Agency

Filed under: Bayer Schering — admin @ 16:1

The action, which will take place from March to May, is implemented through cooperation of the Ministry of Health, the UN Population Fund (UNFPA), Public

(more…)

Bayer Introduces CONTOUR(R) USB - Innovative Plug and Play Technology That … - PR-CANADA.net (press release)

Filed under: Bayer Schering — admin @ 05:1

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

2010-03-05

New clinical analyses from Alpharadin clinical programs to be presented at … - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 19:1

Alpharadin (radium-223 chloride), being developed by Algeta and AG, is a first-in-class alpha-pharmaceutical that has a potent and

(more…)

Germany Pharmaceuticals And Healthcare Report Q2 2010 - New Market Report … - OfficialWire (press release)

Filed under: Bayer Schering — admin @ 16:1

Germany remains a strong domestic industry and a major medical exporter. Several leading multinationals such as - and Boehringer

(more…)

Bayer kasvaa Turussa - MediUutiset

Filed under: Bayer Schering — admin @ 16:1

Uusia seiniä ryhdytään hyvin todennäköisesti pystyttämään lähimmän kolmen vuoden kuluessa, Oy:n varatoimitusjohtaja Peter Essen sanoi

(more…)

Hysterectomy for bleeding may cause urinary woes - Reuters

Filed under: Bayer Schering — admin @ 07:1

and it is generally not recommended for women with a history of PID. Less serious but more common side effects include ovarian cysts, headaches and acne

(more…)

Интерактивные проекционные решения GB frame в Харькове - B2Blogger.com (пресс-релиз)

Filed under: Bayer Schering — admin @ 05:1

Мы предоставили услуги таким известным компаниям как Nokia, Левада, Gira, , Opel, Chery, Mobil 1, Shell, Carte Noire. Принимали участие в выставке «Технология. Реклама. Маркетинг» - «Терем» в Харькове, в автовыставке «Столичное автошоу» в Киеве, в автоквэсте «Мобильный

(more…)

Компания BAYER SCHERING PHARMA снизила цены на популярные контрацептивы - Пресс-релиз.ру (пресс-релиз)

Filed under: Bayer Schering — admin @ 03:1

С учетом экономической ситуации, компания приняла решение снизить цены на 50% на популярные гормональные контрацептивы - МИКРОГИНОН и МИНИЗИСТОН® 20 ФЕМ, что делает их по цене ниже, чем многие дженериковые препараты. Компания - мировой лидер в области

(more…)

2010-03-04

Algeta to present at Cowen’s 30th Annual Health Care Conference - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 18:1

Alpharadin is partnered with AG, a major pharmaceutical company, and is in a global phase III clinical trial (ALSYMPCA) to treat bone

(more…)

Micromet Reports Fourth Quarter and Full Year 2009 Financial Results - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 16:1

Initiated collaboration with for a new BiTE antibody - In December, the Company announced that had exercised its

(more…)

2010-03-02

Ambitionierte Zukäufe: Die größten Übernahmen deutscher Konzerne - Financial Times Deutschland

Filed under: Bayer Schering — admin @ 19:1

Eigentlich hatte der Darmstädter Rivale Merck für den Berliner Schering -Konzern geboten - doch in der Übernahmeschlacht traten die Leverkusener als weißer

(more…)

Bioton of Poland Sees Swing to Profit on Higher Insulin Sales - BusinessWeek

Filed under: Bayer Schering — admin @ 18:1

The company expects to benefit from an agreement last year with AG under which the German drugmaker will distribute Bioton's insulin

(more…)

Bayer voices objections to NICE’s Nexavar rejection - Pharma Times

Filed under: Bayer Schering — admin @ 17:1

“It is so frustrating that for the 600 liver cancer patients who could really benefit from Nexavar, there still remains the chance that they will be denied

(more…)

SCREETON v. BAYER HEALTHCARE PHARMACEUTICALS, INC. - Leagle.com

Filed under: Bayer Schering — admin @ 16:1

Plaintiff's proposed second amended complaint seeks to dismiss Bayer HealthCare, LLC without prejudice and substitute AG as a

(more…)

2010-03-01

Bayer Introduces CONTOUR(R) USB - Innovative Plug and Play Technology That … - SYS-CON Media (press release)

Filed under: Bayer Schering — admin @ 18:1

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

Save the Dates: Algeta to host Capital Markets Days in Oslo (25 May) and … - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 17:1

In September 2009, Algeta entered into a USD 800m global agreement with AG for the development and commercialization of Alpharadin. As

(more…)

2010-02-27

Schering hält Bayer gesund - Tagesspiegel

Filed under: Bayer Schering — admin @ 07:1

Der Bereich Gesundheit (Health Care), zu dem auch die Tochter gehört, wuchs 2009 um vier Prozent auf 16 Milliarden Euro und bestritt

(more…)

2010-02-26

Vorfall bei Bayer Schering Pharma: Salzsäuredämpfe freigesetzt - Derwesten.de

Filed under: Bayer Schering — admin @ 18:1

Wieder hat ein Störfall auf dem Produktionsgelände von am Freitagmorgen die Werksfeuerwehr und die Freiwillige Feuerwehr der Stadt

(more…)

Micromet To Participate in the 2010 RBC Capital Markets Healthcare Conference - Your-Story.org (press release)

Filed under: Bayer Schering — admin @ 18:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of

(more…)

Micromet To Report Fourth Quarter and Full Year 2009 Financial Results on March 4 - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 16:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of CNNMoney.com (press release)

(more…)

Micromet To Participate in the 2010 RBC Capital Markets Healthcare Conference - CNNMoney.com (press release)

Filed under: Bayer Schering — admin @ 04:1

Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including sanofi-aventis, , Merck PR Newswire (press release)

(more…)

NICE to Hear Bayer’s Appeal on the Institute’s Decision not to Recommend NHS … - SYS-CON Media (press release)

Filed under: Bayer Schering — admin @ 04:1

Nicole Farmer , Business Unit Head of Oncology in the UK, said: "It is so frustrating that for the 600 liver cancer patients who could SYS-CON Media (press release)

(more…)

2010-02-25

Регистр пациентов с заболеваниями периферических артерий создадут в РФ - РИА Новости

Filed under: Bayer Schering — admin @ 15:1

МОСКВА, 25 фев – РИА Новости. Регистр пациентов с заболеваниями периферических артерий будет создан в РФ по инициативе Российского общества ангиологов и сосудистых хирургов при поддержке фармацевтической компании , сообщил РИА Новости президент Российского общества

(more…)

2010-02-24

VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With … - PR-USA.net (press release)

Filed under: Bayer Schering — admin @ 19:1

HealthCare, a subsidiary of AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

EBD Group Unveils Additional Program Details for Bio-Europe Spring 2010 - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 18:1

According to event organizers, moderator Diane Romza-Kutz of Troutman Sanders will lead a panel featuring Gordon McCauley, Allon Therapeutics; Graeme Martin

(more…)

People in the News - GenomeWeb Daily News

Filed under: Bayer Schering — admin @ 06:1

Martin Schneider is now chair of the advisory board of imaGenes, the Berlin-based genomics services company said last week. Schneider replaces Klaus Schmidt

(more…)

2010-02-23

Endo upbeat after earnings report - Delaware County Daily Times

Filed under: Bayer Schering — admin @ 19:1

Known as Nebido outside the United States, Aveed was licensed from AG in Germany to Indevus , a Massachusetts company

(more…)

4 pharma firms hit with patent suits in 10 days - mydigitalfc.com

Filed under: Bayer Schering — admin @ 04:1

On February 17 and 18, AG filed two similar patent infringement suits against Lupin following a Paragraph IV certification as part of

(more…)

Итоги работы Компании GB frame в 2009 году - B2Blogger.com (пресс-релиз)

Filed under: Bayer Schering — admin @ 03:1

Мы сотрудничали с такими крупными компаниями как Nokia, Левада, Gira, , Opel, Chery, Mobil 1, Shell. Принимали участие в выставке "Технология. Реклама. Маркетинг" - "Терем" в Харькове, в автовыставке "Столичное автошоу" в Киеве, в автоквэсте "Мобильный десант" - Минск

(more…)

2010-02-22

Pain so severe, some skip school - AsiaOne

Filed under: Bayer Schering — admin @ 15:1

A second study was conducted by last year among 139 students aged 19 to 20 at Raffles Place Park, Republic Polytechnic and Nanyang

(more…)

OC Envoys Nominated - Tempo Interaktif

Filed under: Bayer Schering — admin @ 04:1

TEMPO Interactive, Jakarta:To commemorate 50 years of oral contraceptives/OC use in the world, nominated 40 midwives from 17 provinces

(more…)

Court Report - Patent Docs (blog)

Filed under: Bayer Schering — admin @ 04:1

By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AG et al. v

(more…)

2010-02-20

VEGF Trap-Eye Shows Positive Results In Phase II Study In Patients With … - Medical News Today (press release)

Filed under: Bayer Schering — admin @ 19:1

HealthCare, a subsidiary of AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

26th Annual Joint Patent Practice Seminar - Patent Docs (blog)

Filed under: Bayer Schering — admin @ 18:1

2009) • AG v. Barr Laboratories, Inc. (Fed. Cir. 2009) • Ischemia Research and Education Foundation v. Pfizer (Santa Clara County

(more…)

Algeta Results for the Fourth Quarter and Full Year 2009 - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 17:1

As a result of these achievements, Algeta now has sufficient financial resources to bring Alpharadin to market together with its world-class oncology

(more…)

Movers & Shakers - GenomeWeb Daily News

Filed under: Bayer Schering — admin @ 06:1

Schneider is head of global therapeutic research at . He was previously head of global target discovery and biomarkers at Bayer. Before

(more…)

New endometriosis drug ’safer’ than standard therapy - Healthcare Republic

Filed under: Bayer Schering — admin @ 05:1

It is due to be launched later this year by developer , under the trade name Visanne. Progestogens such as dienogest offer an

(more…)

2010-02-19

Jetzt bewerben: Schering stellt mehr Azubis ein - Derwesten.de

Filed under: Bayer Schering — admin @ 15:1

Die AG erweitert in ihrem Bergkamener Werk ihr Ausbildungsplatzangebot und steigert die Anzahl der Ausbildungsplätze in diesem Jahr

(more…)

Publicis Modem готовится к массированной атаке! - Реклама и маркетинг в Украине

Filed under: Bayer Schering — admin @ 05:1

баннерные коммуникации, промоакции в режиме онлайн, мультимедиа и сетевой «вирусный» маркетинг. Клиенты Publicis Modem: L'Oreal, Renault, LG Electronics, Nestle, Hewlett-Packard, Heineken Brewery, Capital Partners, sanofi-aventis, , Collection-Privee и другие.

(more…)

Publicis Modem готовится к массированной атаке - AdIndex.ru

Filed under: Bayer Schering — admin @ 04:1

баннерные коммуникации, промоакции в режиме онлайн, мультимедиа и сетевой «вирусный» маркетинг. Клиенты Publicis Modem: L'Oreal, Renault, LG Electronics, Nestle, Hewlett-Packard, Heineken Brewery, Capital Partners, sanofi-aventis, , Collection-Privee и другие.

(more…)

Bayer’s A1CNow® SELFCHECK At-Home A1C System Now Available In Local Pharmacies - Diabetes Health (press release)

Filed under: Bayer Schering — admin @ 04:1

The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. The pharmaceuticals business

(more…)

Компания Bayer Schering Pharma снизила цены на популярные контрацептивы - B2Blogger.com (пресс-релиз)

Filed under: Bayer Schering — admin @ 04:1

С учетом экономической ситуации, компания приняла решение снизить цены на 50% на популярные гормональные контрацептивы - МИКРОГИНОН и МИНИЗИСТОН® 20 ФЕМ, что делает их по цене ниже, чем многие дженериковые препараты. Компания - мировой лидер в области

(more…)

2010-02-18

VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With … - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 18:1

HealthCare, a subsidiary of AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

40 Bidan Jadi Duta Kontrasepsi Oral - Vivanews

Filed under: Bayer Schering — admin @ 17:1

Pelantikan bidan bersamaan dengan 50 tahun peringatan kontrasepsi oral (oral contraceptives/OC) di dunia yang merupakan kerjasama antara

(more…)

VEGF Trap-Eye zeigt positive Ergebnisse in Phase-II-Studie bei Patienten mit … - lifepr.de (Pressemitteilung)

Filed under: Bayer Schering — admin @ 16:1

ist ein weltweit führendes Spezialpharma-Unternehmen, dessen Forschung und Geschäftsaktivitäten sich auf vier Bereiche konzentrieren

(more…)

BIO-Europe Spring® 2010 announces additional program highlights - Earthtimes (press release)

Filed under: Bayer Schering — admin @ 07:1

Moderator Diane Romza-Kutz of Troutman Sanders will lead a panel featuring Gordon McCauley, Allon Therapeutics; Graeme Martin, Takeda Research Investment

(more…)

2010-02-17

Melanoma - Drug Pipeline Analysis And Market Forecasts To 2015 - New Market … - OfficialWire (press release)

Filed under: Bayer Schering — admin @ 18:1

Key market players covered are Oncolytics Biotech., Bristol-Myers Squibb, Swedish Orphan International AB AG, Genta Incorporated

(more…)

Farmaceutica: Philogen rileva sito a Siena da Bayer Healthcare - Archivio Radiocor

Filed under: Bayer Schering — admin @ 18:1

Philogen collabora dal 1999 con la , che negli anni scorsi, dopo l'acquisizione da parte di , e' divenuta . A maggio 2009 AGI - Agenzia Giornalistica ItaliaLibero-News.it

(more…)

Sie sind hier: Home > Pressemitteilung: Universität Bonn und Bayer Schering … - Informationsdienst Wissenschaft (Pressemitteilung)

Filed under: Bayer Schering — admin @ 16:1

Die Universität Bonn hat eine Vereinbarung mit der AG zum wissenschaftlichen Austausch getroffen. Das Unternehmen wird sich künftig an

(more…)

Bayer Schering Pharma & ExL Pharma on Leading Events for Digital Marketing … - PR-CANADA.net (press release)

Filed under: Bayer Schering — admin @ 06:1

ExL Digital Europe and European Public Relations & Communications conferences are being held at the Headquarters in

(more…)

2010-02-16

Bayer’s A1CNow(R) SELFCHECK At-Home A1C System Now Available In Local Pharmacies - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 18:1

The company combines the global activities of the Animal Health, Consumer Care, Medical Care and divisions. The business

(more…)

ExL Pharmas führende EU Digital Marketing und PR Konferenz findet am 29. und … - Firmenpresse (Pressemitteilung)

Filed under: Bayer Schering — admin @ 05:1

März 2010 in der Zentrale der AG in Berlin statt New York/Berlin, 14. Februar 2010 – die AG und der

(more…)

2010-02-15

Omnicom, WPP Benefit From Bayer’s Global Consolidation - MediaPost Publications

Filed under: Bayer Schering — admin @ 16:1

The marketing services consolidation involves some 50 brands from four subsidiaries: / HealthCare ,

(more…)

2010-02-14

Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product … - PR-CANADA.net (press release)

Filed under: Bayer Schering — admin @ 03:1

Micromet has collaborations with a number of leading and biotechnology companies, including sanofi-aventis, , Merck

(more…)

2010-02-13

The truth about drug trials - Herald Sun

Filed under: Bayer Schering — admin @ 16:1

“Patients get access to innovative medicines that are often not on the market,” says Dr Robin Wegener, medical director of

(more…)

Bayer’s Global Consolidation Benefits Omnicom, WPP - Adweek

Filed under: Bayer Schering — admin @ 06:1

The marketing services consolidation involves some 50 brands from four subsidiaries: / HealthCare , WebWire (press release)

(more…)

Biologics Data Platform - Scientific Computing

Filed under: Bayer Schering — admin @ 06:1

Genedata and AG have announced a multi-year collaboration for the development and implementation of the Biologics Data Platform (BDP

(more…)

2010-02-12

Bayer HealthCare consolidates with WPP and Omnicom - WebWire (press release)

Filed under: Bayer Schering — admin @ 19:1

HealthCare, a subsidiary of AG, is one of the world's leading, innovative companies in the health care and medical products industry and is

(more…)

Raising Efficiency within Biotechnological Steroid-Production: BRAIN and Bayer … - Business Wire (press release)

Filed under: Bayer Schering — admin @ 19:1

ZWINGENBERG & BERGKAMEN, Germany–(BUSINESS WIRE)–BRAIN AG, an European leader in white biotechnology and the global top 10 corporation Genetic Engineering News (press release)

(more…)

Bayer консолидирует глобальный эккаунт в Omnicom и WPP - AdIndex.ru

Filed under: Bayer Schering — admin @ 17:1

В предмет питча уходили креативные и медиа-обязанности по продвижению 50 брендов четырех дочерних предприятий BHC: / HealthCare , HealthCare Animal Health, HealthCare Consumer Care и HealthCare Medical Care.

(more…)

Algeta schedules Fourth Quarter 2009 Presentation - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 16:1

Alpharadin is partnered with AG, a major company, and is in a global phase III clinical trial (ALSYMPCA) to treat bone

(more…)

Omnicom, WPP to Handle All Bayer HealthCare Creative Work - mediabistro.com (blog)

Filed under: Bayer Schering — admin @ 06:1

The global consolidation, which went into review last July, will cover German-based BHC units / HealthCare and Adweek

(more…)

Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product … - PipelineReview.com (press release)

Filed under: Bayer Schering — admin @ 06:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of

(more…)

2010-02-10

Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product … - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 16:1

Micromet has collaborations with a number of leading and biotechnology companies, including sanofi-aventis, , Merck

(more…)

2010-02-09

Bayer Schering Pharma AG-Company Report - new market report released - PR-inside.com (press release)

Filed under: Bayer Schering — admin @ 18:1

AG-Company Report is a private Company Report that provides up to date insight into the structure and operations of privately-held

(more…)

2010-02-08

Bayer Schering Pharma & ExL Pharma on Leading Events for Digital Marketing … - Market Wire (press release)

Filed under: Bayer Schering — admin @ 17:1

NEW YORK, NY–(Marketwire - February 8, 2010) - ExL Digital Europe and European Public Relations & Communications conferences are being held

(more…)

Micromet to Present at the 12th Annual BIO CEO & Investor Conference - PR-CANADA.net (press release)

Filed under: Bayer Schering — admin @ 16:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of

(more…)

2010-02-07

Report: Clinical Phase Transition Percentage For Novel Kinase Inhibitor … - OfficialWire (press release)

Filed under: Bayer Schering — admin @ 05:1

The report profiles 83 companies including many key and niche players worldwide such as Amgen, Inc., Asahi Kasei Corporation, AstraZeneca plc.,

(more…)

Report: Leading Biologic Drugs For Rheumatoid Arthritis Worldwide (2007 … - OfficialWire (press release)

Filed under: Bayer Schering — admin @ 04:1

The report profiles 115 companies including many key and niche players worldwide such as Abbott Laboratories, Amgen Inc., AG, Biogen

(more…)

2010-02-06

Micromet to Present at the 12th Annual BIO CEO & Investor Conference - PharmaLive (press release) (subscription)

Filed under: Bayer Schering — admin @ 16:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of

(more…)

2010-02-05

Fuji takes its digital portfolio to the next level - Diagnostic Imaging

Filed under: Bayer Schering — admin @ 07:1

The company last week bought intellectual property from covering some 45 patents for a wide range of fluorescent agents and imaging

(more…)

BIO-Europe Spring® 2010 to make Barcelona the hub for biotech dealmaking in March - Benzinga

Filed under: Bayer Schering — admin @ 07:1

Almirall, and Merck Serono, will be among many companies sponsoring BIO-Europe Spring this year; Amgen, AstraZeneca

(more…)

Singapore to lead three new liver cancer trials - AsiaOne

Filed under: Bayer Schering — admin @ 05:1

But, in recent years, companies such as , Norvatis and Sirtex Medical have become increasingly interested in the group's

(more…)

2010-02-04

Joint project in steroids research - Pharmacy Europe

Filed under: Bayer Schering — admin @ 19:1

Brain and are to use optimised microbial production strains sourced from plant-derived raw materials. Highly developed micro-organisms

(more…)

Biocon and Bayer Join Hands to Create Awareness for Self Monitoring in Diabetics - Business Wire India (press release)

Filed under: Bayer Schering — admin @ 16:1

HealthCare, a subsidiary of AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based

(more…)

Micromet to Host Annual Research & Development Day on February 10, 2010 - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 16:1

Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of

(more…)

2010-02-03

BIO-Europe Spring® 2010 to make Barcelona the hub for biotech dealmaking in March - Business Wire (press release)

Filed under: Bayer Schering — admin @ 18:1

The development of partnerships between emerging biotech innovators, big firms, as well as research organizations will support the continued

(more…)

Bayer Schering Pharma:: Mikroorganismen in Höchstform - Derwesten.de

Filed under: Bayer Schering — admin @ 06:1

Ein geringerer Energieverbrauch, eine effizentere Ausbeute und die Verringerung von Treibhausgasen bei der Produktion von Hormonwirkstoffen im Bergakamener Märkische AllgemeineÄrzte Zeitung

(more…)

Algeta announces first patient treated in phase II trial of Alpharadin to … - PipelineReview.com (press release)

Filed under: Bayer Schering — admin @ 06:1

In September 2009, Algeta entered into a $800 million global agreement with AG for the development and commercialization of Alpharadin

(more…)

2010-02-02

VisEn acquires fluorescence agent and technology platforms from Bayer - istockAnalyst.com (press release)

Filed under: Bayer Schering — admin @ 19:1

(Source: Datamonitor)VisEn Medica, a provider of fluorescence in vivo imaging, has acquired the fluorescence imaging agent intellectual property portfolios

(more…)

PRESSEMITTEILUNG/DDP DIRECT Effizienzsteigerung bei biotechnologischer Steroid … - Märkische Allgemeine

Filed under: Bayer Schering — admin @ 18:1

(ddp direct) Die BRAIN AG, ein in Europa führendes Weißes Biotechnologie-Unternehmen aus Zwingenberg und das global agierende Pharmaunternehmen Ärzte Zeitung

(more…)

Bayer Schering Pharma and BRAIN Team Up to Improve Efficiency of Steroid Synthesis - Genetic Engineering News (press release)

Filed under: Bayer Schering — admin @ 18:1

and BRAIN are pooling their expertise to develop methods for the energy-efficient and sustainable production of steroid compounds by Business Wire (press release)

(more…)

Algeta announces first patient treated in phase II trial of Alpharadin to … - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 06:1

In September 2009, Algeta entered into a $800 million global agreement with AG for the development and commercialization of Alpharadin

(more…)

2010-02-01

Journalistenpreis „Advances in Renal Cancer“ 2010 ausgeschrieben - PresseAnzeiger (Pressemitteilung)

Filed under: Bayer Schering — admin @ 17:1

HealthCare ist eine Tochtergesellschaft der AG und gehört zu den weltweit führenden innovativen Unternehmen in der Gesundheitsversorgung mit

(more…)

Hormonbombe oder Mikropille? - Welt Online

Filed under: Bayer Schering — admin @ 16:1

Schon bald danach, im Jahr 1961, brachte das Berliner Pharmaunternehmen (heute ) den ersten europäischen Ovulationshemmer

(more…)

Neujahrsempfang des Campus Berlin-Buch - InnoMonitor (Pressemitteilung)

Filed under: Bayer Schering — admin @ 06:1

Der Vorstandsvorsitzende der AG, Andreas Fibig, betonte in seinem Gastvortrag die Notwendigkeit von strategischen Partnerschaften

(more…)

2010-01-31

MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical … - PR-USA.net (press release)

Filed under: Bayer Schering — admin @ 19:1

AG is the owner of the Paccocath trademark and technology and is developing it for market through affiliate, MEDRAD Inc. under

(more…)

Monthly malady - Malaysia Star

Filed under: Bayer Schering — admin @ 06:1

Dr SY Chong is medical advisor with . For further information, visit www.primanora.com. The information provided is for educational and

(more…)

The Week in Review: Suzhou Nanomed Funded by Softbank - Emerginvest

Filed under: Bayer Schering — admin @ 04:1

announced it is beginning a Phase IV trial among an Asia Pacific population that combines two blood pressure medications: Adalat

(more…)

2010-01-30

Bayer Schering Develops New Data-Management Platform Tailored for Biologics - GenomeWeb Daily News

Filed under: Bayer Schering — admin @ 03:1

By Vivien Marx is putting in place a new data-management platform built specifically for biologics research — an R&D area that has

(more…)

2010-01-29

Pharmabranche vor Herausforderungen 2010 - Branchentreffen in Wiesbaden - TeleTrader

Filed under: Bayer Schering — admin @ 19:1

Februar treffen sich Vertreter der Pharmabranche wie der Chef der Pharmasparte von Merck mit Kollegen von oder auch Sanofi-Aventis in

(more…)

MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical … - PharmiWeb.com (press release)

Filed under: Bayer Schering — admin @ 16:1

AG is the owner of the Paccocath trademark andtechnology and is developing it for market through affiliate, MEDRADInc. under the

(more…)

2010-01-28

VisEn picks up Bayer imaging IP - Mass Device

Filed under: Bayer Schering — admin @ 18:1

VisEn Medical Inc. acquired a 45-patent portfolio of fluorescent imaging intellectual property from German giant . VisEn Medical Inc PR Newswire (press release)

(more…)

Medrad and B Braun Melsungen sign licensing agreement - Trading Markets (press release)

Filed under: Bayer Schering — admin @ 18:1

is the owner of the Paccocath trademark and technology and is developing it for market through affiliate, Medrad, under the

(more…)

MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical … - PR Newswire (press release)

Filed under: Bayer Schering — admin @ 05:1

AG is the owner of the Paccocath trademark and technology and is developing it for market through affiliate, MEDRAD Inc. under

(more…)

2010-01-27

NICE recommends all patients admitted to hospital are risk assessed for VTE - Pharmacy Europe

Filed under: Bayer Schering — admin @ 19:1

To assist with the practical implementation of VTE risk assessment and prevention (BSP) launches a thromboprophylaxis toolkit. VTE

(more…)

Newer Posts »

Powered by WordPress